FAP and neoplasm: HEK-FAP xenografts were monitored for regrowth out to the end of the study (day 42), with 3 and 9 tumor-free (< 10 mm3) mice out of 10 in the 30 and 60 MBq 177Lu-FAP-2286 treatment groups, respectively.